Orphan
Besides the increasing number of categorized GPCRs with assigned endogenous ligands and (partially) elucidated signaling pathways, a large number of GPCRs remain whose endogenous ligands are unknown, and are classified as orphan GPCRs. Traditionally this class of GPCRs has been difficult to study and although molecular biological and bioinformatics techniques made the identification of orphan GPCRs amenable, the development of therapeutic compounds targeting these receptors has been extremely slow. Nevertheless, these GPCRs are considered important targets based on their distribution and behavioral phenotype as revealed by animals lacking the receptor[1] and [2].
[1] S Chung et al. Orphan GPCR research. Br J Pharmacol. 2008 Mar;153 Suppl 1:S339-46.
[2] JA Stockert et al. Advancements in therapeutically targeting orphan GPCRs. Front Pharmacol. 2015 May 8;6:100.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
2915 | CID 1375606 | Analog of CID 5157334 | €95.00 | |
3926 | CID 5157334 | Selective surrogate agonist for GPR27 | €95.00 | |
2962 | FTBMT | Potent, selective and orally available GPR52 agonist | €125.00 | |
2569 | JNJ 63533054 | Potent, brain-penetrant, selective agonist of GPR139 | €90.00 | |
3269 | PSB-KD107 | Selective agonist for GPR18 | €140.00 | |
3486 | TM-N1324 | Highly potent and selective GPR39 agonist | €110.00 |